CBIO peer analysis
Crescent Biopharma (CBIO) against its competitors: price, today's move, 1-year return and market value side by side.
- CBIO's peers: CGEN (Compugen), CLDX (Celldex Therapeutics), CMPX (Compass Therapeutics), CNTX (Context Therapeutics), CTMX (CytomX Therapeutics), MGNX (MacroGenics), NBP (NovaBridge Biosciences), RCUS (Arcus Biosciences).
CBIO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CGEN Compugen | $1.88 | -4.08% | 17.50% | $178.08M |
| CLDX Celldex Therapeutics | $27.40 | -2.00% | 9.95% | $2.15B |
| CMPX Compass Therapeutics | $0.67 | -0.87% | -86.27% | $121.13M |
| CNTX Context Therapeutics | $0.17 | 1.32% | -85.59% | $15.49M |
| CTMX CytomX Therapeutics | $2.04 | -0.34% | -43.72% | $445.41M |
| MGNX MacroGenics | $1.98 | -0.01% | 39.43% | $126.53M |
| NBP NovaBridge Biosciences | $0.88 | -2.58% | -80.58% | $101.41M |
| RCUS Arcus Biosciences | $15.50 | -1.77% | -23.34% | $2.23B |
| VRXA Veraxa Biotech | $1.03 | 0.00% | – | $145.65M |
| ZYME Zymeworks | $26.14 | -2.68% | 15.66% | $1.82B |
| CBIO Crescent Biopharma | $13.00 | 0.70% | -0.23% | $505.64M |